Time Course of Normalization of Functional β-Cell Capacity in the Diabetes Remission Clinical Trial After Weight Loss in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess functional β-cell capacity in type 2 diabetes during 2 years of remission induced by dietary weight loss. RESEARCH DESIGN AND METHODS: A Stepped Insulin Secretion Test with Arginine was used to quantify functional β-cell capacity by hyperglycemia and arginine stimulation. Thirty-nine of 57 participants initially achieved remission (HbA1c <6.5% [<48 mmol/mol] and fasting plasma glucose <7 mmol/L on no antidiabetic drug therapy) with a 16.4 ± 7.7 kg weight loss and were followed up with supportive advice on avoidance of weight regain. At 2 years, 20 participants remained in remission in the study. A nondiabetic control (NDC) group, matched for age, sex, and weight after weight loss with the intervention group, was studied once. RESULTS: During remission, median (interquartile range) maximal rate of insulin secretion increased from 581 (480–811) pmol/min/m2 at baseline to 736 (542–998) pmol/min/m2 at 5 months, 942 (565–1,240) pmol/min/m2 at 12 months (P = 0.028 from baseline), and 936 (635–1,435) pmol/min/m2 at 24 months (P = 0.023 from baseline; n = 20 of 39 of those initially in remission). This was comparable to the NDC group (1,016 [857–1,507] pmol/min/m2) by 12 (P = 0.064) and 24 (P = 0.244) months. Median first-phase insulin response increased from baseline to 5 months (42 [4–67] to 107 [59–163] pmol/min/m2; P < 0.0001) and then remained stable at 12 and 24 months (110 [59–201] and 125 [65–166] pmol/min/m2, respectively; P < 0.0001 vs. baseline) but lower than that of the NDC group (250 [226–429] pmol/min/m2; P < 0.0001). CONCLUSIONS: A gradual increase in assessed functional β-cell capacity occurred after weight loss, becoming similar to that of NDC group participants by 12 months. This result was unchanged at 2 years with continuing remission of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“was consolidated by mechanistic studies from a DiRECT subset. 7-9”
From 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study (2024) · cites this paper as [7]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095 · cited 4×
“type 2 diabetes at 2 years using a simple, effective dietary method (17,19,20).”
BackgroundMethodInfluentialSelf-citationU.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure
Talchai, C., Xuan, S., Lin, H. V., Sussel, L., & Accili, D. (2012) · Cell · doi:10.1016/j.cell.2012.07.029 · Cited by 1,415
Lim, E. L., Hollingsworth, K. G., Aribisala, B. S., Chen, M. J., Mathers, J. C., & Taylor, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2204-7 · Cited by 1,164 · cited 6×
“The protocol for DiRECT was informed by the Counterpoint study and the early results of the Counterbalance study, which showed no return of first-phase insulin secretion beyond 11 years of diagnosis (15,16).”
BackgroundMethodInfluentialSelf-citationFatty acid-induced β cell apoptosis: A link between obesity and diabetes
Shimabukuro, M., Zhou, Y.-T., Levi, M., & Unger, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2498 · Cited by 1,142
Lean, M. E. J., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30068-3 · Cited by 1,017 · cited 3×
“type 2 diabetes at 2 years using a simple, effective dietary method (17,19,20).”
BackgroundMethodSelf-citationLee, Y., Hirose, H., Ohneda, M., Johnson, J. H., McGarry, J. D., & Unger, R. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10878 · Cited by 836
Pancreatic β‐cell mass in European subjects with type 2 diabetes
Rahier, J., Guiot, Y., Goebbels, R. M., Sempoux, C., & Henquin, J. C. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00969.x · Cited by 756
RNA Sequencing of Single Human Islet Cells Reveals Type 2 Diabetes Genes
Xin, Y., Kim, J., Okamoto, H., Ni, M., Wei, Y., Adler, C., Murphy, A. J., Yancopoulos, G. D., Lin, C., & Gromada, J. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.018 · Cited by 692
Cited by
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Chan, J. C. N., Lim, L.-L., Wareham, N. J., Shaw, J. E., Orchard, T. J., Zhang, P., Lau, E. S. H., Eliasson, B., Kong, A. P. S., Ezzati, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32374-6 · Cited by 793
Intra-pancreatic fat deposition: bringing hidden fat to the fore
Petrov, M. S., & Taylor, R. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00551-0 · Cited by 195
Self-citationLima, J. E. B. F., Moreira, N. C. S., & Sakamoto-Hojo, E. T. (2022) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2021.503437 · Cited by 203
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Kelly, T., Irvine, K., Peters, C., Zhyzhneuskaya, S., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00385-6 · Cited by 186
Self-citationSandforth, A., von Schwartzenberg, R. J., Arreola, E. V., Hanson, R. L., Sancar, G., Katzenstein, S., Lange, K., Preißl, H., Dreher, S. I., Weigert, C., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00235-8 · Cited by 100
Type 2 diabetes and remission: practical management guided by pathophysiology
Taylor, R. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13214 · Cited by 81
Self-citationUnderstanding the cause of type 2 diabetes
Taylor, R. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00157-8 · Cited by 95
Self-citationUnwin, D., Delon, C., Unwin, J., Tobin, S., & Taylor, R. (2023) · BMJ Nutrition, Prevention & Health · doi:10.1136/bmjnph-2022-000544 · Cited by 72
Self-citationTaylor, R., Barnes, A. C., Hollingsworth, K. G., Irvine, K. M., Solovyova, A. S., Clark, L., Kelly, T., Martin-Ruiz, C., Romeres, D., Koulman, A., et al. (2023) · Clinical Science · doi:10.1042/cs20230586 · Cited by 71
“Although functional β -cell mass has been shown to return completely to normal during 12 months of dietary weight loss-induced remission of T2D, first phase insulin secretion improves but does not normalise either in the present or previous studies [30].”
Self-citationNutritional basis of type 2 diabetes remission
Taylor, R., Ramachandran, A., Yancy, W. S., & Forouhi, N. G. (2021) · BMJ · doi:10.1136/bmj.n1449 · Cited by 59
Self-citationPrevention of cardiorenal complications in people with type 2 diabetes and obesity
Drucker, D. J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.12.018 · Cited by 67
The role of adipose tissue dysfunction in hepatic insulin resistance and T2D
Sancar, G., & Birkenfeld, A. L. (2024) · Journal of Endocrinology · doi:10.1530/joe-24-0115 · Cited by 79
Molecular mechanisms of lipotoxicity-induced pancreatic β-cell dysfunction
Benito‐Vicente, A., Jebari‐Benslaiman, S., Galicia-García, U., Larrea, A., Uribe, K. B., & Martín, C. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.02.013 · Cited by 65
Prediabetes remission for type 2 diabetes mellitus prevention
Birkenfeld, A. L., & Mohan, V. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00996-8 · Cited by 49
Henquin, J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101212 · Cited by 55
First-phase insulin secretion: can its evaluation direct therapeutic approaches?
Di Giuseppe, G., Ciccarelli, G., Soldovieri, L., Capece, U., Cefalo, C. M. A., Moffa, S., Nista, E. C., Brunetti, M., Cinti, F., Gasbarrini, A., et al. (2023) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2023.02.001 · Cited by 46
“In this context, restoring β cell function could be the game-changer in preventing and treating diabetes, as demonstrated by the Diabetes Remission Clinical Trial (DiRECT) in which diabetic subjects showed improved β cell function and partial restoration of first-phase insulin secretion after weight loss over a 2 year…”
Prevention of type 2 diabetes through prediabetes remission without weight loss
Sandforth, A., Arreola, E. V., Hanson, R. L., Albrechtsen, N. J. W., Holst, J. J., Ahrends, R., Coman, C., Gerst, F., Lorza‐Gil, E., Cheng, Y., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03944-9 · Cited by 53
Al-Mrabeh, A. H. (2021) · Biomedicines · doi:10.3390/biomedicines9020226 · Cited by 46
Self-citationThe role of the beta cell in type 2 diabetes: new findings from the last 5 years
Yau, B., Ghislain, J. J., Kebede, M. A., Hughes, J. W., & Poitout, V. (2025) · Diabetologia · doi:10.1007/s00125-025-06499-z · Cited by 51
Lupoli, R., Lembo, E., Ciciola, P., Schiavo, L., Pilone, V., & Capaldo, B. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.06.029 · Cited by 41
The Pancreatic ß-cell Response to Secretory Demands and Adaption to Stress
Kalwat, M. A., Scheuner, D., Rodrigues-dos-Santos, K., Eizirik, D. L., & Cobb, M. H. (2021) · Endocrinology · doi:10.1210/endocr/bqab173 · Cited by 43
Nutrient Regulation of Pancreatic Islet β-Cell Secretory Capacity and Insulin Production
Rohli, K. E., Boyer, C. K., Blom, S. E., & Stephens, S. B. (2022) · Biomolecules · doi:10.3390/biom12020335 · Cited by 41
The β-cell glucose toxicity hypothesis: Attractive but difficult to prove
Weir, G. C., Butler, P. C., & Bonner‐Weir, S. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154870 · Cited by 38
Pathogenesis and remission of type 2 diabetes: what has the twin cycle hypothesis taught us?
Al-Mrabeh, A. H. (2020) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000201 · Cited by 38
Self-citationZhu, J., Han, J., Liu, L., Liu, Y., Xu, W., Li, X., Yang, L., Gu, Y., Tang, W., Shi, Y., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110568 · Cited by 34
Not Control but Conquest: Strategies for the Remission of Type 2 Diabetes Mellitus
Kim, J., & Kwon, H. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0377 · Cited by 33
Fujihara, K., KHIN, L. M., Murai, K., Yamazaki, Y., Tsuruoka, K., Yagyuda, N., Yamazaki, K., Maegawa, H., Tanaka, S., Kodama, S., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15100 · Cited by 29
Revisiting the Pattern of Loss of β-Cell Function in Preclinical Type 1 Diabetes
Martino, M., Galderisi, A., Evans‐Molina, C., & Dayan, C. M. (2024) · Diabetes · doi:10.2337/db24-0163 · Cited by 21
Retnakaran, R. R., Pu, J., Shen, J., Hanley, A. J., & Zinman, B. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00163-9 · Cited by 20
Yildirim, V., Sheraton, V. M., Brands, R., Crielaard, L., Quax, R., van Riel, N. A. W., Stronks, K., Nicolaou, M., & Sloot, P. M. A. (2023) · iScience · doi:10.1016/j.isci.2023.108324 · Cited by 19
Treat Obesity to Treat Type 2 Diabetes Mellitus
Sulu, C., & Yumuk, V. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01536-3 · Cited by 24
Cao, H., Chung, A. C. K., Ming, X., Mao, D., Lee, H. M., Cao, X., Rutter, G. A., Chan, J. C. N., Tian, X. Y., & Kong, A. P. S. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101493 · Cited by 17
Furusawa, S., Nomoto, H., Yokoyama, H., Suzuki, Y., Tsuzuki, A., Takahashi, K., Miya, A., Kameda, H., Cho, K. Y., Takeuchi, J., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15393 · Cited by 19
Janssen, J. A. M. J. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189191 · Cited by 20
Beta‐cell function in type 2 diabetes ( T2DM ): Can it be preserved or enhanced?
Kassem, L. S., Rajpal, A., Barreiro, M. V. E., & Ismail‐Beigi, F. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13446 · Cited by 16
de Hoogh, I. M., Pasman, W. J., Boorsma, A., van Ommen, B., & Wopereis, S. (2022) · Biomedicines · doi:10.3390/biomedicines10030643 · Cited by 17
Cardioprotective benefits of metabolic surgery and GLP-1 receptor agonist–based therapies
Morissette, A., & Mulvihill, E. E. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.07.012 · Cited by 13
Fujihara, K., KHIN, L. M., Murai, K., Yamazaki, Y., Tsuruoka, K., Yagyuda, N., Yamazaki, K., Maegawa, H., Tanaka, S., Kodama, S., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15206 · Cited by 10
Body mass cycling and predictors of body mass regain and its impact on cardiometabolic health
Cornejo, M. A., & Ortiz, R. M. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154912 · Cited by 9
Schwartz, S. S., Corkey, B. E., Gavin, J. R., DeFronzo, R. A., & Herman, M. E. (2024) · BMC Medicine · doi:10.1186/s12916-024-03518-5 · Cited by 12
Aetiology of type 2 diabetes: an experimental medicine odyssey
Taylor, R. (2025) · Diabetologia · doi:10.1007/s00125-025-06428-0 · Cited by 10
Self-citationGower, B. A., YURCHISHIN, M. L., Goss, A. M., Knight, J. L., & Garvey, W. T. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf324 · Cited by 8
Physiology Reconfigured: How Does Bariatric Surgery Lead to Diabetes Remission?
Albaugh, V. L., Axelrod, C. L., Belmont, K. P., & Kirwan, J. P. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.06.003 · Cited by 9
The Twin Cycle Hypothesis of type 2 diabetes aetiology: From concept to national NHS programme
Taylor, R. (2025) · Experimental Physiology · doi:10.1113/ep092009 · Cited by 7
Self-citationNomoto, H., Furusawa, S., Yokoyama, H., Suzuki, Y., Izumihara, R., Oe, Y., Takahashi, K., Miya, A., Kameda, H., Cho, K. Y., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae213 · Cited by 5
Zhu, R., Guo, J., Huttunen‐Lenz, M., Stratton, G., Swindell, N. J., Macdonald, I. A., Handjieva‐Darlenska, T., Handjiev, S., Navas‐Carretero, S., Poppitt, S. D., et al. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156546 · Cited by 4
Sul, H. H., Ahmad, S., Danpanichkul, P., Mantovani, A., de Souza, M. H. G., & Petrov, M. S. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00718-3 · Cited by 6
Remission of type 2 diabetes by weight loss in a non-white population
Taylor, R. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30147-9 · Cited by 3
Self-citationParadigmenwechsel in den Empfehlungen zur Ernährung bei Typ-2-Diabetes
Lechner, K., McKenzie, A. L., & Worm, N. (2021) · Info Diabetologie · doi:10.1007/s15034-020-3646-0 · Cited by 3
Type 2 diabetes remission: latest evidence for health care professionals
Taylor, R. (2020) · Practical Diabetes · doi:10.1002/pdi.2297 · Cited by 3
Self-citationCommentary on the Impact of Obesity and Puberty on Insulin Sensitivity
Haymond, M. W., & Chung, S. T. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa104 · Cited by 3
Diabetes remission and nonalcoholic fatty pancreas disease
Wu, W. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i7.1390 · Cited by 6
Fischer, J. S., Hepprich, M., Cattaneo, M., Seeger, L., Dobler, S., & Donath, M. Y. (2026) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00527.2025 · Cited by 2
Modelling remission from overweight type 2 diabetes reveals how altering advice may counter relapse
Sweatman, C. Z. W. H. (2024) · Mathematical Biosciences · doi:10.1016/j.mbs.2024.109180 · Cited by 2
The Cardiovascular and Macrovascular Benefits of Achieving Early Type 2 Diabetes Remission
Khachikyan, L., & Shubrook, J. H. (2025) · Diabetology · doi:10.3390/diabetology6100120 · Cited by 2
Yan, W., Zhang, Z., Feng, Z., Wu, T., Xia, J., Pan, D., Xia, H., Liao, W., Wang, S. Q., Yang, L., et al. (2026) · Food Science and Human Wellness · doi:10.26599/fshw.2026.9251086 · Cited by 1
Forget polypharmacy for type 2 diabetes! Weight management is a better investment
Lean, M. E. J., McCombie, L., & Xin, Y. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa250 · Cited by 1
Self-citationErnährungsempfehlungen bei Typ-2-Diabetes: Grundlegendes Umdenken
Worm, N., McKenzie, A. L., & Lechner, K. (2021) · Deutsches Ärzteblatt · doi:10.3238/persdia.2021.11.05.06 · Cited by 1
Typ-2-Diabetes: Langfristige Remission durch ernährungsbedingte Abnahme
(2020) · Diabetologie und Stoffwechsel · doi:10.1055/a-1199-9399
Precision Medical Management Strategies for Diabetes Remission
Kashyap, S. R., & Borgan, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-98927-9_10
Utzschneider, K. M., Ehrmann, D. A., Arslanian, S. A., Barengolts, E., Buchanan, T. A., Caprio, S., Edelstein, S. L., Hannon, T. S., Kahn, S. E., Kozedub, A., et al. (2022) · Obesity · doi:10.1002/oby.23475
Intervening at the stage of metabolic syndrome to prevent type 2 diabetes—Is it justified?
Satpathi, T., Unnikrishnan, R., & Mohan, V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00014-1
The Whole Human Pancreas: An Understudied Organ in Diabetes
Taylor, R. (2024) · Diabetes · doi:10.2337/dbi23-0021
Self-citationDietary intervention enhances fertility in obese male mice by regulating SLC2As
Sun, L., Hong, X., Zhu, Q., Xiang, Y., Xu, C., Weng, L., Cai, J., Liang, N., Xue, M., & Ge, H. (2025) · Journal of Molecular Histology · doi:10.1007/s10735-025-10470-y
Long-term remission of impaired glucose tolerance in the finnish diabetes prevention study
Uusitupa, M., Valtanen, M., Lindström, J., & Tuomilehto, J. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113222
Sun, H., Shen, Y., Burke, S. J., Brantley, P. J., Brock, R., Zhang, D., Yang, S., Hu, G., & Collier, J. J. (2026) · International Journal of Obesity · doi:10.1038/s41366-026-02070-x
The role of noradrenergic innervation and β-cell dedifferentiation in diabetes
AVOLIO, A., Morciano, C., Gugliandolo, S., Splendore, A., Capece, U., Mezza, T., Giuseppe, G. D., Ciccarelli, G., Soldovieri, L., Brunetti, M., et al. (2026) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2026.04.005
Lalama, E., Zhang, J., Schuppelius, B., Csanalosi, M., Rüther, K. J. A., Kabisch, S., Mai, K., Kraenkel, N., Latz, E., Christ, A., et al. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113382
Modelling Type 2 Diabetes: Investigating Relapse Post Remission
Sweatman, C. Z. W. H. (2026) · Springer proceedings in mathematics & statistics · doi:10.1007/978-3-032-17956-2_1
Kale, M. C., Purandare, V. B., Tiwari, S., Aherkar, J., Kulkarni, G., Manekar, S., & Unnikrishnan, A. (2026) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2026.103487
Metadata
- Authors
- Zhyzhneuskaya, S. V., Al-Mrabeh, A., Peters, C., Barnes, A., Aribisala, B., Hollingsworth, K. G., McConnachie, A., Sattar, N., Lean, M. E. J., & Taylor, R.
- Affiliations
- Newcastle University (GB)
- Lagos State University (NG)
- University of Glasgow (GB)
- Corresponding author
- Taylor, Roy
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-02-14
- Volume
- 43
- Issue
- 4
- Pages
- 813-820
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W3005947520
- Cited by
- 70
- References
- 45
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 14 · 2023: 10 · 2022: 7 · 2021: 11 · 2020: 10
- FWCI
- 8.68
- Type
- journal article
- Language
- en
- Open access
- green
- eprints.gla.ac.uk
- Licence
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- Funders
- Diabetes UK (13/0004691)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, diabetes remission, weight loss, beta-cell function, insulin secretion, first-phase insulin response, arginine stimulation, weight regain prevention, sustained remission, HbA1c, fasting blood glucose, insulin resistance, HOMA-IR
- MeSH terms
- Insulin Secretion, Adult, Aged, Diabetes Mellitus, Type 2, Female, Humans, Insulin, Male, Middle Aged, Reference Values, Remission Induction, Time Factors, Weight Loss, Treatment Outcome, Recovery of Function, Insulin-Secreting Cells, Young Adult, Weight Reduction Programs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.